Beximco Pharmaceuticals Ltd DR BXP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX 41.00
- Day Range
- GBX 40.00–40.00
- 52-Week Range
- GBX 33.30–45.00
- Bid/Ask
- GBX 39.00 / GBX 42.00
- Market Cap
- GBX 17.84 Bil
- Volume/Avg
- 8,899 / 55,752
Key Statistics
- Price/Earnings (Normalized)
- 4.64
- Price/Sales
- 0.54
- Dividend Yield (Trailing)
- 6.13%
- Dividend Yield (Forward)
- 4.86%
- Total Yield
- 6.71%
Company Profile
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 5,700
- Website
- https://www.beximcopharma.com
Comparables
Valuation
|
Metric
|
BXP
|
4114
|
BEACONPHAR
|
|---|---|---|---|
Price/Earnings (Normalized) | 4.64 | 24.67 | 64.35 |
Price/Book Value | 0.51 | 2.27 | 6.50 |
Price/Sales | 0.54 | 2.84 | 4.37 |
Price/Cash Flow | — | 19.10 | — |
Price/Earnings
BXP
4114
BEACONPHAR
Financial Strength
|
Metric
|
BXP
|
4114
|
BEACONPHAR
|
|---|---|---|---|
Quick Ratio | 0.70 | 1.19 | 0.39 |
Current Ratio | 1.80 | 1.87 | 1.22 |
Interest Coverage | 7.08 | 11.42 | 1.76 |
Quick Ratio
BXP
4114
BEACONPHAR
Profitability
|
Metric
|
BXP
|
4114
|
BEACONPHAR
|
|---|---|---|---|
Return on Assets (Normalized) | 7.64% | 3.77% | 4.32% |
Return on Equity (Normalized) | 11.97% | 7.04% | 10.35% |
Return on Invested Capital (Normalized) | 10.74% | 4.58% | 9.14% |
Return on Assets
BXP
4114
BEACONPHAR
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Lgjqfyrl | Kwqkv | $76.6 Bil | |
MKKGY
| Merck KGaA ADR | Svzghpjxh | Kkqkwh | $72.3 Bil | |
HLN
| Haleon PLC ADR | Hfrrpyjl | Wtdr | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Yqfvdbns | Yytt | $18.3 Bil | |
VTRS
| Viatris Inc | Smjqjqlq | Mbf | $13.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Zvlbgjv | Wsmn | $11.8 Bil | |
CTLT
| Catalent Inc | Sqsdrdmcm | Dmcqtz | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Vxqrdvg | Ydfyk | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Nnstqcf | Bbzv | $4.2 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Bssynnsc | Kpssctl | $3.5 Bil |